Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.54 |
| ▸ | HTR1A | P08908 | 3/20 | 0.52 |
| ▸ | DRD2 | P14416 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9532652 | 0.86 | DRD2 (0.56) | SIGMAR1HTR1ADRD2KDM4EADRA2C | |
| SCHEMBL9765996 | 0.83 | SIGMAR1 (0.52) | SIGMAR1HTR1ADRD2KDM4ECYP1A2 | |
| SCHEMBL12504550 | 0.80 | TMEM97 (0.44) | SIGMAR1HTR1ADRD2KDM4EDRD4 | |
| SCHEMBL7957399 | 0.80 | DRD2 (0.58) | SIGMAR1HTR1ADRD2GAADRD4 | |
| SCHEMBL11861074 | 0.78 | CYP1A2 (0.53) | CYP1A2GAAHRH1 | |
| SCHEMBL12412543 | 0.78 | HRH3 (0.43) | SIGMAR1HTR1ADRD2KDM4EDRD4 | |
| SCHEMBL9400880 | 0.78 | HTT (0.55) | KDM4EGAA | |
| SCHEMBL21528177 | 0.78 | OGA (0.43) | SIGMAR1HTR1ADRD2ADRA2CDRD4 | |
| SCHEMBL23251897 | 0.77 | OGA (0.47) | SIGMAR1HTR1ADRD2ADRA2CDRD4 | |
| SCHEMBL25678432 | 0.77 | OGA (0.47) | SIGMAR1HTR1ADRD2ADRA2CDRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4994460-A | Treatment or prevention of disorders resulting from central nervous system anoxia | BRISTOL-MYERS SQUIBB CO. (US) | 1991-02-19 | — | — | US | disclosed |
| EP-0400661-A1 | Agents for treatment of brain ischemia | Bristol-Myers Squibb Company (US) | 1990-12-05 | — | — | EP | disclosed |